中性粒细胞与淋巴细胞、血小板与淋巴细胞和肾炎细胞比值升高与肾癌术后主要并发症的关系:优化Charlson合并症指数和术前预测模型的途径

IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY
Giacomo Musso, Natalie Birouty, Andrea Salonia, Giuseppe Garofano, Mai Dabbas, Margaret F Meagher, Kit L Yuen, Benjamin Baker, Cesare Saitta, Dattatraya Patil, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Francesco Montorsi, Alberto Briganti, Umberto Capitanio, Alessandro Larcher, Giuseppe Rosiello, Yasuhisa Fujii, Viraj A Master, Ithaar H Derweesh
{"title":"中性粒细胞与淋巴细胞、血小板与淋巴细胞和肾炎细胞比值升高与肾癌术后主要并发症的关系:优化Charlson合并症指数和术前预测模型的途径","authors":"Giacomo Musso, Natalie Birouty, Andrea Salonia, Giuseppe Garofano, Mai Dabbas, Margaret F Meagher, Kit L Yuen, Benjamin Baker, Cesare Saitta, Dattatraya Patil, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Francesco Montorsi, Alberto Briganti, Umberto Capitanio, Alessandro Larcher, Giuseppe Rosiello, Yasuhisa Fujii, Viraj A Master, Ithaar H Derweesh","doi":"10.1016/j.urology.2025.06.052","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the predictive value of De Ritis ratio (DRR), Neutrophil-to-Lymphocyte Ratio (NLR), and Platelet-to-Lymphocyte Ratio (PLR) for major post-operative complications following Renal Cell Carcinoma (RCC) surgery, and to assess their predictive utility in addition to Charlson Comorbidity Index (CCI).</p><p><strong>Methods: </strong>We conducted a multicenter retrospective analysis of patients who underwent surgery for M0 RCC. Primary outcome was the occurrence of major complication (Clavien-Dindo >2). Optimal thresholds for DRR, NLR, and PLR were identified using Akaike Information Criterion (AIC). Multivariable logistic regression (MVA) assessed associations between biomarkers and complications, adjusting for CCI, estimated glomerular filtration rate (eGFR), tumor size, surgery type, pT/pN stage, R.E.N.A.L. score. Predictive performance was evaluated using the Area under Curves (AUC) from ROC curves. Internal validation was performed with 1000-sample bootstrapping.</p><p><strong>Results: </strong>Among 4122 patients, 198 (4.8%) experienced major complications [urinary leak (n = 90, 35.7% of all major complications), bleeding/hematoma (n = 38, 15.1%), and cardiac events (n = 15, 6.0%)]. AIC identified thresholds of 2.3 for elevated DRR (EDRR), 2.7 for NLR (ENLR), and 200 for PLR (EPLR). 191 (4.6%), 1243 (30.2%), and 684 (16.6%) patients had elevated EDRR, ENL, and EPLR. On MVA, all three biomarkers independently predicted major complications: EDRR [Odds ratio (OR) = 3.06, P = .02], ENLR (OR = 1.25, P = .01), EPLR (OR = 1.30, P = .01). AUCs were 0.63 for CCI alone, 0.77 with additional covariates, and 0.85 for the model with all biomarkers. Bootstrapped AUC for the full model was 0.77.</p><p><strong>Conclusion: </strong>Preoperative DRR, NLR, and PLR improve prediction of major complications after RCC surgery in addition to CCI. Our findings point towards an enhanced model to risk stratify and optimize patient outcomes in RCC surgery.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive Modeling.\",\"authors\":\"Giacomo Musso, Natalie Birouty, Andrea Salonia, Giuseppe Garofano, Mai Dabbas, Margaret F Meagher, Kit L Yuen, Benjamin Baker, Cesare Saitta, Dattatraya Patil, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Francesco Montorsi, Alberto Briganti, Umberto Capitanio, Alessandro Larcher, Giuseppe Rosiello, Yasuhisa Fujii, Viraj A Master, Ithaar H Derweesh\",\"doi\":\"10.1016/j.urology.2025.06.052\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To evaluate the predictive value of De Ritis ratio (DRR), Neutrophil-to-Lymphocyte Ratio (NLR), and Platelet-to-Lymphocyte Ratio (PLR) for major post-operative complications following Renal Cell Carcinoma (RCC) surgery, and to assess their predictive utility in addition to Charlson Comorbidity Index (CCI).</p><p><strong>Methods: </strong>We conducted a multicenter retrospective analysis of patients who underwent surgery for M0 RCC. Primary outcome was the occurrence of major complication (Clavien-Dindo >2). Optimal thresholds for DRR, NLR, and PLR were identified using Akaike Information Criterion (AIC). Multivariable logistic regression (MVA) assessed associations between biomarkers and complications, adjusting for CCI, estimated glomerular filtration rate (eGFR), tumor size, surgery type, pT/pN stage, R.E.N.A.L. score. Predictive performance was evaluated using the Area under Curves (AUC) from ROC curves. Internal validation was performed with 1000-sample bootstrapping.</p><p><strong>Results: </strong>Among 4122 patients, 198 (4.8%) experienced major complications [urinary leak (n = 90, 35.7% of all major complications), bleeding/hematoma (n = 38, 15.1%), and cardiac events (n = 15, 6.0%)]. AIC identified thresholds of 2.3 for elevated DRR (EDRR), 2.7 for NLR (ENLR), and 200 for PLR (EPLR). 191 (4.6%), 1243 (30.2%), and 684 (16.6%) patients had elevated EDRR, ENL, and EPLR. On MVA, all three biomarkers independently predicted major complications: EDRR [Odds ratio (OR) = 3.06, P = .02], ENLR (OR = 1.25, P = .01), EPLR (OR = 1.30, P = .01). AUCs were 0.63 for CCI alone, 0.77 with additional covariates, and 0.85 for the model with all biomarkers. Bootstrapped AUC for the full model was 0.77.</p><p><strong>Conclusion: </strong>Preoperative DRR, NLR, and PLR improve prediction of major complications after RCC surgery in addition to CCI. Our findings point towards an enhanced model to risk stratify and optimize patient outcomes in RCC surgery.</p>\",\"PeriodicalId\":23415,\"journal\":{\"name\":\"Urology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-06-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.urology.2025.06.052\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.urology.2025.06.052","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:评价德炎比(DRR)、中性粒细胞与淋巴细胞比(NLR)、血小板与淋巴细胞比(PLR)对RCC术后主要并发症的预测价值,并结合Charlson合并症指数(CCI)评估其预测价值。方法:我们对接受M0型肾细胞癌手术的患者进行了多中心回顾性分析。主要预后指标为主要并发症的发生(Clavien-Dindo>2)。采用赤池信息标准(Akaike Information Criterion, AIC)确定DRR、NLR和PLR的最佳阈值。多变量logistic回归(MVA)评估了生物标志物与并发症之间的关系,调整了CCI、eGFR、肿瘤大小、手术类型、pT/pN分期、R.E.N.A.L.评分。使用ROC曲线的曲线下面积(AUC)评估预测性能。内部验证是通过1000个样本的bootstrapping进行的。结果:4122例患者中,198例(4.8%)出现主要并发症[尿漏(n=90,占所有主要并发症的35.7%)、出血/血肿(n=38,占15.1%)、心脏事件(n=15,占6.0%)]。AIC确定了DRR升高(EDRR)的阈值为2.3,NLR (ENLR)的阈值为2.7,PLR (EPLR)为200。191例(4.6%)、1243例(30.2%)和684例(16.6%)患者EDRR、ENL和EPLR升高。在MVA中,三种生物标志物均能独立预测主要并发症:EDRR[比值比(OR)=3.06, p=0.02]、ENLR (OR=1.25, p=0.01)、EPLR (OR=1.30, p=0.01)。单独CCI的auc为0.63,附加协变量的auc为0.77,包含所有生物标志物的模型的auc为0.85。完整模型的bootstrap AUC为0.77。结论:术前DRR、NLR和PLR除CCI外,还能提高对RCC术后主要并发症的预测。我们的研究结果指向一个增强模型,以风险分层和优化RCC手术患者的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive Modeling.

Objective: To evaluate the predictive value of De Ritis ratio (DRR), Neutrophil-to-Lymphocyte Ratio (NLR), and Platelet-to-Lymphocyte Ratio (PLR) for major post-operative complications following Renal Cell Carcinoma (RCC) surgery, and to assess their predictive utility in addition to Charlson Comorbidity Index (CCI).

Methods: We conducted a multicenter retrospective analysis of patients who underwent surgery for M0 RCC. Primary outcome was the occurrence of major complication (Clavien-Dindo >2). Optimal thresholds for DRR, NLR, and PLR were identified using Akaike Information Criterion (AIC). Multivariable logistic regression (MVA) assessed associations between biomarkers and complications, adjusting for CCI, estimated glomerular filtration rate (eGFR), tumor size, surgery type, pT/pN stage, R.E.N.A.L. score. Predictive performance was evaluated using the Area under Curves (AUC) from ROC curves. Internal validation was performed with 1000-sample bootstrapping.

Results: Among 4122 patients, 198 (4.8%) experienced major complications [urinary leak (n = 90, 35.7% of all major complications), bleeding/hematoma (n = 38, 15.1%), and cardiac events (n = 15, 6.0%)]. AIC identified thresholds of 2.3 for elevated DRR (EDRR), 2.7 for NLR (ENLR), and 200 for PLR (EPLR). 191 (4.6%), 1243 (30.2%), and 684 (16.6%) patients had elevated EDRR, ENL, and EPLR. On MVA, all three biomarkers independently predicted major complications: EDRR [Odds ratio (OR) = 3.06, P = .02], ENLR (OR = 1.25, P = .01), EPLR (OR = 1.30, P = .01). AUCs were 0.63 for CCI alone, 0.77 with additional covariates, and 0.85 for the model with all biomarkers. Bootstrapped AUC for the full model was 0.77.

Conclusion: Preoperative DRR, NLR, and PLR improve prediction of major complications after RCC surgery in addition to CCI. Our findings point towards an enhanced model to risk stratify and optimize patient outcomes in RCC surgery.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Urology
Urology 医学-泌尿学与肾脏学
CiteScore
3.30
自引率
9.50%
发文量
716
审稿时长
59 days
期刊介绍: Urology is a monthly, peer–reviewed journal primarily for urologists, residents, interns, nephrologists, and other specialists interested in urology The mission of Urology®, the "Gold Journal," is to provide practical, timely, and relevant clinical and basic science information to physicians and researchers practicing the art of urology worldwide. Urology® publishes original articles relating to adult and pediatric clinical urology as well as to clinical and basic science research. Topics in Urology® include pediatrics, surgical oncology, radiology, pathology, erectile dysfunction, infertility, incontinence, transplantation, endourology, andrology, female urology, reconstructive surgery, and medical oncology, as well as relevant basic science issues. Special features include rapid communication of important timely issues, surgeon''s workshops, interesting case reports, surgical techniques, clinical and basic science review articles, guest editorials, letters to the editor, book reviews, and historical articles in urology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信